Amphastar Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AMPH Nasdaq 2836 www.amphastar.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amphastar Pharmaceuticals, Inc.

New Strong Sell Stocks for June 23rd - Jun 23rd, 2026 3:13 am
1 Healthcare Stock to Consider Right Now and 2 We Brush Off - Jun 12th, 2026 2:54 am
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth - Jun 10th, 2026 5:08 pm
How The Investment Story For Amphastar Pharmaceuticals (AMPH) Is Evolving Without New Valuation Shifts - Jun 9th, 2026 4:17 pm
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag - Jun 3rd, 2026 10:02 pm
Amphastar Pharmaceuticals, Inc. (AMPH) Price Target Cut to $21 At Piper Sandler Amid Pipeline Uncertainty - Jun 2nd, 2026 8:10 am
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference - May 27th, 2026 4:00 am
3 Stocks Under $50 with Open Questions - May 26th, 2026 4:51 am
Why Wells Fargo Lowered Amphastar Pharmaceuticals, Inc. (AMPH) Price Target to $19 - May 20th, 2026 2:43 pm
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today - May 18th, 2026 12:28 pm
The 5 Most Interesting Analyst Questions From Amphastar Pharmaceuticals’s Q1 Earnings Call - May 17th, 2026 11:24 am
Q1 Earnings Roundup: Amphastar Pharmaceuticals (NASDAQ:AMPH) And The Rest Of The Pharmaceuticals Segment - May 16th, 2026 3:56 am
Amphastar Pharmaceuticals' (NASDAQ:AMPH) Conservative Accounting Might Explain Soft Earnings - May 15th, 2026 4:40 am
Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook - May 14th, 2026 12:05 am
How The Amphastar Pharmaceuticals (AMPH) Narrative Is Shifting As Targets Fall And New Drugs Launch - May 12th, 2026 10:16 am
Earnings Miss: Amphastar Pharmaceuticals, Inc. Missed EPS By 75% And Analysts Are Revising Their Forecasts - May 11th, 2026 5:41 am
Amphastar Pharmaceuticals (AMPH) Is Up 9.4% After Profit Falls Despite New Drug Launches And Licensing Deals - May 9th, 2026 2:21 am
Amphastar Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary - May 8th, 2026 6:30 am
Amphastar (AMPH) Q1 2026 Earnings Transcript - May 7th, 2026 6:04 pm
Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics - May 7th, 2026 6:00 pm